Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2015-004956-23Phase 4Active
Phase 4, open-label trial of avatrombopag in None (2 arms), sponsored by Hospital de la Santa Creu i Sant Pau Research Institute. Primary endpoint: Number of menstrual bleeding days. Started Jan 2016; status: active.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2015-004956-23.